Literature DB >> 15676122

The delivery of benzyl penicillin to Staphylococcus aureus biofilms by use of liposomes.

Hee-Jeong Kim1, Malcolm N Jones.   

Abstract

The delivery of benzyl penicillin [penicillin G (pen-G)] encapsulated in cationic liposomes to a pen-G-sensitive strain of Staphylococcus aureus immobilized in biofilms has been investigated. The cationic liposomes prepared by extrusion (VETs, diameter approximately 140 nm) were composed of dipalmitoylphosphatidylcholine (DPPC), cholesterol, and dimethylammonium ethane carbamoyl cholesterol (DC-chol) at a molar ratio of 1.0:0.49:0.43. This composition containing 22 mole% of the cationic lipid DC-chol has been found previously (Kim et al. Colloids Surfaces A 1999, 149, 561-570) to be optimum for adsorption of the liposomes on S. aureus biofilms. The effectiveness of the liposomes to deliver pen-G to the biofilms immobilized on microtitre plates was assessed from the rate of growth of the cells after exposure to the liposomal drug carrier relative to free pen-G at the same concentration. The time to reach maximum growth rate from biofilms was investigated as a function of overall drug concentration in a range 2.9 x 10- 3 mM to 1.09 mM and as a function of time of exposure to liposomal drug in a range 1.5 s to 2 h. Liposomal drug delivery was most effective relative to free drug at low overall drug concentrations and short times of exposure. The time to reach maximum growth rate from S. aureus biofilms could be extended by a factor of approximately 4 relative to free drug by the use of liposomally encapsulated pen-G. The results were supported by direct measurements of the distribution of pen-G between biofilm and supernatant which showed enhanced values relative to free drug and a transient preferential uptake of drug induced by the liposomes. The study demonstrates that for low drug concentrations and short exposure times liposomal drug delivery greatly enhances the effectiveness of pen-G for inhibiting the growth of bacterial biofilms of the potentially pathogenic bacterium Staphylococcus aureus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15676122     DOI: 10.1081/lpr-200029887

Source DB:  PubMed          Journal:  J Liposome Res        ISSN: 0898-2104            Impact factor:   3.648


  11 in total

1.  Nanoparticles: Emerging carriers for drug delivery.

Authors:  Sagar R Mudshinge; Amol B Deore; Sachin Patil; Chetan M Bhalgat
Journal:  Saudi Pharm J       Date:  2011-04-21       Impact factor: 4.330

2.  Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection.

Authors:  Dissaya Pornpattananangkul; Li Zhang; Sage Olson; Santosh Aryal; Marygorret Obonyo; Kenneth Vecchio; Chun-Ming Huang; Liangfang Zhang
Journal:  J Am Chem Soc       Date:  2011-02-23       Impact factor: 15.419

3.  Antibacterial Activity of Vancomycin Encapsulated in Poly(DL-lactide-co-glycolide) Nanoparticles Using Electrospraying.

Authors:  Elzaan Booysen; Martin Bezuidenhout; Anton Du Preez van Staden; Dimiter Dimitrov; Shelly M Deane; Leon M T Dicks
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

Review 4.  Current Trends in Development of Liposomes for Targeting Bacterial Biofilms.

Authors:  Zora Rukavina; Željka Vanić
Journal:  Pharmaceutics       Date:  2016-05-24       Impact factor: 6.321

5.  Self-enhanced targeted delivery of a cell wall- and membrane-active antibiotics, daptomycin, against staphylococcal pneumonia.

Authors:  Hong Jiang; Meimei Xiong; Qiuyan Bi; Ying Wang; Chong Li
Journal:  Acta Pharm Sin B       Date:  2016-06-11       Impact factor: 11.413

6.  Nanoemulsions of Green Tea Catechins and Other Natural Compounds for the Treatment of Urinary Tract Infection: Antibacterial Analysis.

Authors:  Atinderpal Kaur; Reema Gabrani; Shweta Dang
Journal:  Adv Pharm Bull       Date:  2019-08-01

7.  Fusogenic Liposomes Increase the Antimicrobial Activity of Vancomycin Against Staphylococcus aureus Biofilm.

Authors:  Andreia Borges Scriboni; Verônica Muniz Couto; Lígia Nunes de Morais Ribeiro; Irlan Almeida Freires; Francisco Carlos Groppo; Eneida de Paula; Michelle Franz-Montan; Karina Cogo-Müller
Journal:  Front Pharmacol       Date:  2019-11-29       Impact factor: 5.810

Review 8.  Antimicrobial photodynamic inactivation in nanomedicine: small light strides against bad bugs.

Authors:  Rui Yin; Tanupriya Agrawal; Usman Khan; Gaurav K Gupta; Vikrant Rai; Ying-Ying Huang; Michael R Hamblin
Journal:  Nanomedicine (Lond)       Date:  2015       Impact factor: 5.307

Review 9.  Prevention and treatment of biofilms by hybrid- and nanotechnologies.

Authors:  Ramanathan K Kasimanickam; Ashish Ranjan; G V Asokan; Vanmathy R Kasimanickam; John P Kastelic
Journal:  Int J Nanomedicine       Date:  2013-08-02

10.  Optimized Preparation of Levofloxacin Loaded Polymeric Nanoparticles.

Authors:  Manuel López-López; Angela Fernández-Delgado; María Luisa Moyá; Daniel Blanco-Arévalo; Cecilio Carrera; Rafael R de la Haba; Antonio Ventosa; Eva Bernal; Pilar López-Cornejo
Journal:  Pharmaceutics       Date:  2019-01-30       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.